Santucci Neha R, Beigarten Alan J, Khalid Fatima, El-Chammas Khalil I, Graham Kahleb, Sahay Rashmi, Fei Lin, Rich Kristin, Mellon Michael
Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Neuromodulation. 2024 Feb;27(2):372-381. doi: 10.1016/j.neurom.2023.07.005. Epub 2023 Aug 16.
Functional dyspepsia (FD) includes postprandial distress and epigastric pain syndrome. Percutaneous electrical nerve field stimulation (PENFS) in addition to behavioral interventions (BI) has shown benefits in children with functional abdominal pain but not specifically in FD. We aimed to assess the efficacy of PENFS for treating FD and compare the outcomes with those who received the combination of PENFS + BI.
Charts of patients with FD who completed four weeks of PENFS were evaluated. A subset of patients received concurrent BI. Demographic data, medical history, and symptoms were documented. Outcomes at different time points included subjective symptom responses and validated questionnaires collected clinically (Abdominal Pain Index [API], Nausea Severity Scale [NSS], Functional Disability Inventory [FDI], Pittsburgh Sleep Quality Index [PSQI], Children's Somatic Symptoms Inventory [CSSI], Patient-Reported Outcomes Measurement Information Systems [PROMIS] Pediatric Anxiety and Depression scales).
Of 84 patients, 61% received PENFS + BI, and 39% received PENFS alone. In the entire cohort, API (p < 0.0001), NSS (p = 0.001), FDI (p = 0.001), CSSI (p < 0.0001), PSQI (p = 0.01), PROMIS anxiety (p = 0.02), and depression (p = 0.01) scores improved from baseline to three weeks and at three months. Subjective responses showed nausea improvement (p = 0.01) and a trend for improvement in abdominal pain (p = 0.07) at week three. Abdominal pain subjectively improved at week three and three months (p = 0.003 and 0.02, respectively), nausea at week three and three months (p = 0.01 and 0.04, respectively), and a trend for improvement in sleep disturbances at week three and three months (p = 0.08 and p = 0.07, respectively) in the PENFS + BI group vs PENFS alone.
Abdominal pain, nausea, functioning, somatization, sleep disturbances, anxiety, and depression improved at three weeks and three months after PENFS in pediatric FD. Subjective pain and nausea improvement were greater in the PENFS + BI group than in the group with PENFS alone, suggesting an additive effect of psychologic therapy.
功能性消化不良(FD)包括餐后不适和上腹痛综合征。经皮电神经场刺激(PENFS)联合行为干预(BI)已显示对功能性腹痛儿童有益,但对FD儿童的疗效尚不明确。我们旨在评估PENFS治疗FD的疗效,并将结果与接受PENFS + BI联合治疗的患者进行比较。
对完成四周PENFS治疗的FD患者病历进行评估。部分患者同时接受BI。记录人口统计学数据、病史和症状。不同时间点的结果包括主观症状反应和临床收集的有效问卷(腹痛指数[API]、恶心严重程度量表[NSS]、功能残疾量表[FDI]、匹兹堡睡眠质量指数[PSQI]、儿童躯体症状量表[CSSI]、患者报告结局测量信息系统[PROMIS]儿童焦虑和抑郁量表)。
84例患者中,61%接受PENFS + BI,39%仅接受PENFS。在整个队列中,从基线到三周及三个月时,API(p < 0.0001)、NSS(p = 0.001)、FDI(p = 0.001)、CSSI(p < 0.0001)、PSQI(p = 0.01)、PROMIS焦虑(p = 0.02)和抑郁(p = 0.01)评分均有所改善。主观反应显示,在第三周时恶心改善(p = 0.01),腹痛有改善趋势(p = 0.07)。与仅接受PENFS的组相比,PENFS + BI组在第三周和三个月时腹痛主观改善(分别为p = 0.003和0.02),恶心在第三周和三个月时改善(分别为p = 0.01和0.04),睡眠障碍在第三周和三个月时有改善趋势(分别为p = 0.08和p = 0.07)。
小儿FD患者在接受PENFS治疗三周和三个月后,腹痛、恶心、功能、躯体化、睡眠障碍、焦虑和抑郁均有所改善。PENFS + BI组的主观疼痛和恶心改善程度大于仅接受PENFS的组,提示心理治疗具有附加效应。